NYLIM
BSTG

New York Life Investment Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

New York Life Investment Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,464
Closed -$5K – 280
2015
Q1 		$5K Hold
1,464
– – ﹤0.01% 247
2014
Q4 		$5K Sell
1,464
-346
-19% -$1.71K ﹤0.01% 261
2014
Q3 		$15K Hold
1,810
– – ﹤0.01% 194
2014
Q2 		$19K Buy
+1,810
New +$15.4K ﹤0.01% 198

Other funds holding BSTG

State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WIC
Woodmont Investment Counsel Nashville, Tennessee $1.83B AUM 25.91% 1-Year Est. Return

New York Life Investment Management's BSTG Position: Q2 2015 in Review

New York Life Investment Management sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2015, closing a stake of 1,464 shares — an estimated $5K sold.

New York Life Investment Management first reported a position in BSTG in Q2 2014 and held it in 4 quarters. The position peaked at $19K in Q2 2014. 32 funds tracked by Wall St. Rank hold BSTG as of Q2 2015.

  • New York Life Investment Management reported no remaining Biostage, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • New York Life Investment Management sold 1,464 Biostage, Inc. Common Stock shares in Q2 2015, an estimated $5K.
  • New York Life Investment Management first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • New York Life Investment Management's Biostage, Inc. Common Stock position peaked at $19K in Q2 2014.
  • 32 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2015.

Based on New York Life Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.